Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects
NCT06151808
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
XTR006
Sponsor
Sinotau Pharmaceutical Group